Vemulapalli S, Chiu P J, Rivelli M, Foster C J, Sybertz E J
Department of Pharmacology, Schering-Plough Research, Bloomfield, New Jersey 07003.
J Cardiovasc Pharmacol. 1991 Dec;18(6):895-903. doi: 10.1097/00005344-199112000-00017.
We have developed separate radioimmunoassays to measure circulating ET-1 and ET-3 levels in normotensive and different hypertensive rat models so that the role of endothelin in the regulation of vasomotor function can be studied. We also assessed the stimulatory effects of endotoxin on plasma and liver lymph ET-1 and ET-3 levels. The circulating ET-1 levels in normotensive rats, SHRs, and DOCA-salt hypertensive rats were 2.3 +/- 0.5, 2.1 +/- 0.4, and 2.1 +/- 0.9 pg/ml, respectively. Similarly, the plasma ET-3 levels in normotensive and different hypertensive rats were similar, ranging from 19.7 +/- 1.5 to 24.7 +/- 2.2 pg/ml. The data indicate that steady-state circulating levels of endothelins are a poor correlate of the hypertensive state. Endotoxin (30 mg/kg i.v. over 15 min) reduced blood pressure significantly and augmented plasma ET-1 levels by sevenfold (29.1 +/- 3.7 vs. 4.1 +/- 0.6 pg/ml in the vehicle group; p less than 0.05) and ET-3 levels by twofold (47.7 +/- 7.0 vs. 22.7 +/- 4.0 pg/ml in the vehicle group; p less than 0.05). Human TNF-alpha (30 ng/kg/min x 30 min), a putative mediator of endotoxin shock, enhanced plasma ET-1 (18.3 +/- 1.0 vs. 2.7 +/- 0.4 pg/ml in the vehicle group; p less than 0.05) by sevenfold and ET-3 levels by twofold (45.7 +/- 2.0 vs. 27.1 +/- 4.0 pg/ml in the vehicle group; p less than 0.05) without affecting blood pressure.(ABSTRACT TRUNCATED AT 250 WORDS)
我们已开发出单独的放射免疫分析法,用于测量正常血压和不同高血压大鼠模型中循环内皮素-1(ET-1)和内皮素-3(ET-3)的水平,以便研究内皮素在血管舒缩功能调节中的作用。我们还评估了内毒素对血浆和肝淋巴中ET-1和ET-3水平的刺激作用。正常血压大鼠、自发性高血压大鼠(SHRs)和去氧皮质酮盐性高血压大鼠的循环ET-1水平分别为2.3±0.5、2.1±0.4和2.1±0.9 pg/ml。同样,正常血压和不同高血压大鼠的血浆ET-3水平相似,范围为19.7±1.5至24.7±2.2 pg/ml。数据表明,内皮素的稳态循环水平与高血压状态的相关性较差。内毒素(静脉注射30 mg/kg,持续15分钟)显著降低血压,并使血浆ET-1水平增加7倍(载体组为4.1±0.6 pg/ml,处理组为29.1±3.7 pg/ml;p<0.05),使ET-3水平增加2倍(载体组为22.7±4.0 pg/ml,处理组为47.7±7.0 pg/ml;p<0.05)。人肿瘤坏死因子-α(TNF-α)(30 ng/kg/min×30分钟),一种假定的内毒素休克介质,使血浆ET-1水平增加7倍(载体组为2.7±0.4 pg/ml,处理组为18.3±1.0 pg/ml;p<0.05),使ET-3水平增加2倍(载体组为27.1±4.0 pg/ml,处理组为45.7±2.0 pg/ml;p<0.05),而不影响血压。(摘要截断于250字)